VAERS ID: 2331047

AGE: | SEX: F|STATE: FR

Description

lymph node swelling in the jaw; Development of basalioma on the forehead; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from the Regulatory Authority. Regulatory number: DE-PEI-CADR2022282402 (RA). Other Case identifier(s): DE-CADRPEI-2022282402 (RA Webportal), DE-PEI-202200086740 (RA). A 48-year-old female patient received BNT162b2 (COMIRNATY), on 15Jun2021 as dose 2, single (Lot number: FD9234) for covid-19 immunisation. The patient's relevant medical history included: "Bee venom" (unspecified if ongoing); "Dexamethasone" (unspecified if ongoing); "Prednisolone" (unspecified if ongoing); "Nuts" (unspecified if ongoing); "Guinea Pig" (unspecified if ongoing); "bronchopneumonia", start date: 2009 (unspecified if ongoing); "small pulmonary embolism", start date: 2013 (unspecified if ongoing); "Hashimoto's thyroiditis" (unspecified if ongoing); "neurodermatitis" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1 Manufacturer Unknown), for COVID-19 immunisation. The following information was reported: BASAL CELL CARCINOMA (medically significant) with onset 26Jul2021, outcome "not recovered", described as "Development of basalioma on the forehead"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "lymph node swelling in the jaw". The patient underwent the following laboratory tests and procedures: tissue samples taken: Basalioma. Therapeutic measures were taken as a result of basal cell carcinoma, lymphadenopathy. The causality assessment for suspect drug to event 'Basalioma' was reported as follows: Source of assessment RA Result of Assessment D. Unclassifiable No follow-up attempts are possible. No further information is expected. No follow-up attempts are possible. No further information is expected.

Symptoms

Basal cell carcinoma, Laboratory test, Lymphadenopathy

Vaccines

VAX DATE: 06-15-2021| ONSET DATE: 07-26-2021| DAYS TO ONSET: 41
NameDose #TypeManufacturerLotRouteSite
COVID19 (COVID19 (PFIZER-BIONTECH)) 2 COVID19 PFIZER\BIONTECH FD9234 Unknown Unknown

RECVDATE:06-24-2022
RPT_DATE:
CAGE_YR:
CAGE_MO:
DIED:U
DATEDIED:
L_THREAT:U
ER_VISIT:U
HOSPITAL:U
HOSPDAYS:
X_STAY:U
DISABLE:U
RECOVD:N
LAB_DATA:Test Name: tissue samples taken; Result Unstructured Data: Test Result:Basalioma
V_ADMINBY:OTH
OTHER_MEDS:
CUR_ILL:
HISTORY:Medical History/Concurrent Conditions: Allergy to animal; Allergy to nuts; Bee sting hypersensitivity; Bronchopneumonia; Drug allergy; Hashimoto's thyroiditis; Neurodermatitis; Pulmonary embolism
PRIOR_VAX:
SPLTTYPE:DEPFIZER INC202200846914
FORM_VERS:2
TODAYS_DATE:06-23-2022
BIRTH_DEFECT:U
OFC_VISIT:U
ER_ED_VISIT:U
ALLERGIES:
V_FUNDBY:

Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.

AND PLEASE read the FAQ first.

OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.